Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Iron Status and IV Iron on Muscle Metabolism
NCT02308449Completed
- Sponsor
- University of Oxford
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferric carboxymaltose in iron deficiency anemia (IDA) (4 arms), sponsored by University of Oxford. Primary endpoint: Phosphocreatine depletion during small muscle mass exercise at 1 week. Started Oct 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02308449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308449.